-
<![CDATA[New Targets Emerge for Aggressive Small Cell Lung Cancer ]]>
16 Sep 2025 23:34 GMT
… the treatment of small cell lung cancer (SCLC) in recent years, … Small cell lung cancer, which makes up about 13% of lung cancers, is … activity such as small cell lung cancer.
What are the clinical … were resistant to first-line chemotherapy, and we saw really …
-
<![CDATA[Osimertinib Plus Chemotherapy Expands Frontline Choices in EGFR+ NSCLC ]]>
17 Sep 2025 03:08 GMT
… Lung Cancer 2025 World Conference on Lung Cancer (WCLC), a panel of lung cancer … Lung Cancer 2025 World Conference on Lung Cancer … Lung Cancer 2025 World Conference on Lung Cancer … chemotherapy vs chemotherapy in EGFR-mutated, advanced non-small cell lung cancer …
-
Osimertinib Plus Chemo Significantly Extends Survival for Patients With Lung Cancer
16 Sep 2025 16:39 GMT
… history of smoking, but EGFRm lung cancers present more in atypical populations … patients with other types of lung cancers, the immune systems in EGFRm … EGFR-mutated lung cancer."1
REFERENCES
1. AstraZeneca. Tagrisso plus chemotherapy demonstrated …
-
Imfinzi becomes first NHS drug for aggressive lung cancer
16 Sep 2025 16:10 GMT
… limited-stage small cell lung cancer (LS-SCLC), a … after concurrent platinum-based chemotherapy and radiation therapy (CRT … limited-stage small cell lung cancer, a disease where progress … chief executive of Roy Castle Lung Cancer Foundation.
"For more …
-
Imfinzi approved for NHS use in limited-stage small cell lung cancer
16 Sep 2025 14:17 GMT
… limited-stage small cell lung cancer (LS-SCLC) whose … 0.0104), regardless of chemotherapy regimen or use of prophylactic … and aggressive form of lung cancer. Although initial responses to … Imfinzi across small cell lung cancer, and reinforces our commitment …
-
Japan’s MHLW approves Novocure’s Optune Lua to treat unresectable advanced/recurrent non-small cell lung cancer
16 Sep 2025 11:35 GMT
… cell lung cancer (NSCLC) who have progressed on or after platinum-based chemotherapy … patients with non-small cell lung cancer experiencing a progression after initial … -small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. It …
-
Amivantamab-lazertinib combo improves overall survival in EGFR-mutated lung cancer in phase 3 trial
16 Sep 2025 03:12 GMT
… , in EGFR-mutated advanced lung cancer, a phase 3 trial showed … or metastatic non-small cell lung cancer (NSCLC), the combination of … possibility that a first-line chemotherapy-free strategy using next- … of care, surpassing conventional chemotherapy.”
-
<![CDATA[Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer]]>
15 Sep 2025 23:10 GMT
… has progressed following platinum-based chemotherapy. In addition to results from … with extensive-stage small cell lung cancer often have limited therapeutic options … of extensive-stage small cell lung cancer.”
Trial design highlights global enrollment …
-
New treatments found to treat small-cell lung cancer
15 Sep 2025 21:44 GMT
… Lung Cancer Foundation of America, this type of cancer responds well to chemotherapy … Collaborative, lung cancer - including small-cell lung cancer - remains … such as the Lung Cancer Foundation of America have … that small-cell lung cancer patients are prepared …
-
Moffitt Researchers Create Machine Learning Model to Forecast Urgent Care Visits in Lung Cancer Patients
15 Sep 2025 21:38 GMT
… for non–small cell lung cancer (NSCLC). This pioneering … .
Systemic therapies, including chemotherapy, immunotherapy, and targeted agents … revolutionize not only lung cancer care but also … article
Moffitt Cancer Center Lung Cancer
References:
DOI: 10. …